Cargando…
CRISPR/Cas9-Mediated Knock-Out of Kras(G12D) Mutated Pancreatic Cancer Cell Lines
In 90% of pancreatic ductal adenocarcinoma cases, genetic alteration of the proto-oncogene Kras has occurred, leading to uncontrolled proliferation of cancerous cells. Targeting Kras has proven to be difficult and the battle against pancreatic cancer is ongoing. A promising approach to combat cancer...
Autores principales: | Lentsch, Eva, Li, Lifei, Pfeffer, Susanne, Ekici, Arif B., Taher, Leila, Pilarsky, Christian, Grützmann, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888344/ https://www.ncbi.nlm.nih.gov/pubmed/31739488 http://dx.doi.org/10.3390/ijms20225706 |
Ejemplares similares
-
Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
por: Zhang, Jinping, et al.
Publicado: (2023) -
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2022) -
CRISPR Cas9 in Pancreatic Cancer Research
por: Yang, Hai, et al.
Publicado: (2019) -
Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells Decreases Pancreatitis-Induced Autophagy
por: Yasunaga, Kohei, et al.
Publicado: (2018) -
Efficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing
por: Kumita, Wakako, et al.
Publicado: (2019)